Hiroshi Nakagomi

9PUBLICATIONS
11CO-AUTHORS
Cancer diagnosisGene expression (incl. microarray and other genome-wide approaches)Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 10, 2025
Key issues in surveillance of secondary breast cancer.

Tomomi Oka, Hiroshi Nakagomi, Ayako Kimura

|Feb 11, 2025
Germline Pathogenic Variants and Clinical Outcomes in Asian Patients With Breast Cancer.

Rui Kitadai, Shu Yazaki, Aya Kuchiba

|Jul 04, 2024
Dynamic change of cancer genome profiling in metachronous bilateral breast cancer with BRCA pathogenic variant.

Ayako Kimura, Hiroshi Nakagomi, Masayuki Inoue

|Oct 03, 2022
Cystic degeneration during neo-adjuvant chemotherapy predicts squamous metaplasia of triple negative breast cancer: report of two cases.

Masayuki Inoue, Ayako Kimura, Tomomi Oka

|Sep 10, 2022
TP53-positive clones are responsible for drug-tolerant persister and recurrence of HER2-positive breast cancer.

Hideki Watanabe, Hiroshi Nakagomi, Yosuke Hirotsu

|Mar 26, 2022
PIK3CA-AKT pathway predominantly acts in developing ipsilateral breast tumor recurrence long after breast-conserving surgery.

Hiroshi Nakagomi, Masayuki Inoue, Yosuke Hirotsu

Pageof 2